Johanna Friedl-Naderer - Chief Commercial Officer at Dyne Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Stock Symbol
DYN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Johanna Friedl-Naderer - trading volume in the past year for Dyne Therapeutics, Inc.

Holdings reported by Johanna Friedl-Naderer for Dyne Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 94.9K $1.27M $13.41 Sep 5, 2025 Direct
Stock option (right to buy) 51.3K Jul 16, 2025 Direct Common Stock

Transactions reported by Johanna Friedl-Naderer for Dyne Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.